$ANDS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANADYS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANADYS PHARMACEUTICALS INC. Get notifications about new insider transactions in ANADYS PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.30 | 352 | 2,922 | 2,496,675 | 2.5 M to 2.5 M (-0.01 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.22 | 1,900 | 15,618 | 2,497,027 | 2.5 M to 2.5 M (-0.08 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.11 | 1,950 | 15,815 | 2,498,927 | 2.5 M to 2.5 M (-0.08 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.10 | 2,600 | 21,060 | 2,500,877 | 2.5 M to 2.5 M (-0.10 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.09 | 1,100 | 8,899 | 2,503,477 | 2.5 M to 2.5 M (-0.04 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.07 | 4,359 | 35,177 | 2,504,577 | 2.5 M to 2.5 M (-0.17 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.05 | 800 | 6,440 | 2,508,936 | 2.5 M to 2.5 M (-0.03 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.04 | 1,950 | 15,678 | 2,509,736 | 2.5 M to 2.5 M (-0.08 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.03 | 4,241 | 34,055 | 2,511,686 | 2.5 M to 2.5 M (-0.17 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.02 | 5,350 | 42,907 | 2,515,927 | 2.5 M to 2.5 M (-0.21 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.01 | 3,800 | 30,438 | 2,521,277 | 2.5 M to 2.5 M (-0.15 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.00 | 9,400 | 75,200 | 2,525,077 | 2.5 M to 2.5 M (-0.37 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.99 | 4,000 | 31,960 | 2,534,477 | 2.5 M to 2.5 M (-0.16 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.98 | 4,450 | 35,511 | 2,538,477 | 2.5 M to 2.5 M (-0.17 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.97 | 15,150 | 120,746 | 2,542,927 | 2.6 M to 2.5 M (-0.59 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.96 | 500 | 3,980 | 2,558,077 | 2.6 M to 2.6 M (-0.02 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.95 | 7,050 | 56,048 | 2,558,577 | 2.6 M to 2.6 M (-0.27 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.94 | 3,699 | 29,370 | 2,565,627 | 2.6 M to 2.6 M (-0.14 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.93 | 4,500 | 35,685 | 2,569,326 | 2.6 M to 2.6 M (-0.17 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.92 | 2,300 | 18,216 | 2,573,826 | 2.6 M to 2.6 M (-0.09 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.91 | 4,799 | 37,960 | 2,576,126 | 2.6 M to 2.6 M (-0.19 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.90 | 6,902 | 54,526 | 2,580,925 | 2.6 M to 2.6 M (-0.27 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.89 | 2,000 | 15,780 | 2,587,827 | 2.6 M to 2.6 M (-0.08 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.88 | 1,900 | 14,972 | 2,589,827 | 2.6 M to 2.6 M (-0.07 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.87 | 4,300 | 33,841 | 2,591,727 | 2.6 M to 2.6 M (-0.17 %) |
Jun 07 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.86 | 600 | 4,716 | 2,596,027 | 2.6 M to 2.6 M (-0.02 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.87 | 428 | 3,796 | 2,586,627 | 2.6 M to 2.6 M (-0.02 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.80 | 2,400 | 21,120 | 2,587,055 | 2.6 M to 2.6 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.79 | 1,100 | 9,669 | 2,589,455 | 2.6 M to 2.6 M (-0.04 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.76 | 290 | 2,540 | 2,590,555 | 2.6 M to 2.6 M (-0.01 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.73 | 2,300 | 20,079 | 2,590,845 | 2.6 M to 2.6 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.70 | 300 | 2,610 | 2,593,145 | 2.6 M to 2.6 M (-0.01 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.68 | 100 | 868 | 2,593,445 | 2.6 M to 2.6 M (0.00 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.64 | 1,900 | 16,416 | 2,593,545 | 2.6 M to 2.6 M (-0.07 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.62 | 1,350 | 11,637 | 2,595,445 | 2.6 M to 2.6 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.61 | 3,090 | 26,605 | 2,596,795 | 2.6 M to 2.6 M (-0.12 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.60 | 5,310 | 45,666 | 2,599,885 | 2.6 M to 2.6 M (-0.20 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.59 | 1,610 | 13,830 | 2,605,195 | 2.6 M to 2.6 M (-0.06 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.58 | 2,300 | 19,734 | 2,606,805 | 2.6 M to 2.6 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.55 | 2,500 | 21,375 | 2,609,105 | 2.6 M to 2.6 M (-0.10 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.52 | 6,470 | 55,124 | 2,611,605 | 2.6 M to 2.6 M (-0.25 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.51 | 9,750 | 82,973 | 2,618,075 | 2.6 M to 2.6 M (-0.37 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.50 | 1,391 | 11,824 | 2,627,825 | 2.6 M to 2.6 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.49 | 2,000 | 16,980 | 2,629,216 | 2.6 M to 2.6 M (-0.08 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.48 | 50 | 424 | 2,631,216 | 2.6 M to 2.6 M (0.00 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.47 | 1,000 | 8,470 | 2,631,266 | 2.6 M to 2.6 M (-0.04 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.46 | 2,909 | 24,610 | 2,632,266 | 2.6 M to 2.6 M (-0.11 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.45 | 1,800 | 15,210 | 2,635,175 | 2.6 M to 2.6 M (-0.07 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.43 | 3,050 | 25,712 | 2,636,975 | 2.6 M to 2.6 M (-0.12 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.42 | 800 | 6,736 | 2,640,025 | 2.6 M to 2.6 M (-0.03 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.41 | 6,080 | 51,133 | 2,640,825 | 2.6 M to 2.6 M (-0.23 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.40 | 4,800 | 40,320 | 2,646,905 | 2.7 M to 2.6 M (-0.18 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.39 | 600 | 5,034 | 2,651,705 | 2.7 M to 2.7 M (-0.02 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.38 | 2,300 | 19,274 | 2,652,305 | 2.7 M to 2.7 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.37 | 1,700 | 14,229 | 2,654,605 | 2.7 M to 2.7 M (-0.06 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.36 | 3,800 | 31,768 | 2,656,305 | 2.7 M to 2.7 M (-0.14 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.35 | 3,900 | 32,565 | 2,660,105 | 2.7 M to 2.7 M (-0.15 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.33 | 2,200 | 18,326 | 2,664,005 | 2.7 M to 2.7 M (-0.08 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.32 | 4,200 | 34,944 | 2,666,205 | 2.7 M to 2.7 M (-0.16 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.31 | 1,300 | 10,803 | 2,670,405 | 2.7 M to 2.7 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.30 | 6,450 | 53,535 | 2,671,705 | 2.7 M to 2.7 M (-0.24 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.29 | 1,400 | 11,606 | 2,678,155 | 2.7 M to 2.7 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.26 | 100 | 826 | 2,679,555 | 2.7 M to 2.7 M (0.00 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.25 | 1,750 | 14,438 | 2,679,655 | 2.7 M to 2.7 M (-0.07 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.23 | 1,200 | 9,876 | 2,681,405 | 2.7 M to 2.7 M (-0.04 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.22 | 1,850 | 15,207 | 2,682,605 | 2.7 M to 2.7 M (-0.07 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.21 | 1,600 | 13,136 | 2,684,455 | 2.7 M to 2.7 M (-0.06 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.19 | 1,300 | 10,647 | 2,686,055 | 2.7 M to 2.7 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.15 | 3,900 | 31,785 | 2,687,355 | 2.7 M to 2.7 M (-0.14 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.14 | 2,300 | 18,722 | 2,691,255 | 2.7 M to 2.7 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.11 | 2,400 | 19,464 | 2,693,555 | 2.7 M to 2.7 M (-0.09 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.10 | 6,300 | 51,030 | 2,695,955 | 2.7 M to 2.7 M (-0.23 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.05 | 1,300 | 10,465 | 2,702,255 | 2.7 M to 2.7 M (-0.05 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.04 | 2,000 | 16,080 | 2,703,555 | 2.7 M to 2.7 M (-0.07 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.02 | 1,200 | 9,624 | 2,705,555 | 2.7 M to 2.7 M (-0.04 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.01 | 1,000 | 8,010 | 2,706,755 | 2.7 M to 2.7 M (-0.04 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 8.00 | 400 | 3,200 | 2,707,755 | 2.7 M to 2.7 M (-0.01 %) |
Jun 06 2005 | ANDS | ANADYS PHARMACEUTI ... | HBM BIOVENTURES AG | 10% Owner | Sell | S | 7.94 | 2,100 | 16,674 | 2,708,155 | 2.7 M to 2.7 M (-0.08 %) |
Jun 02 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | M | 2.95 | 25,400 | 74,930 | 196,078 | |
Jun 02 2005 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Buy | M | 2.95 | 25,400 | 74,930 | 26,352 | 952 to 26.4 K (+2,668.07 %) |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 2.95 | 241 | 711 | 0 | |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 6.88 | 2,206 | 15,177 | 3,677 | |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 6.88 | 2,960 | 20,365 | 61,746 | |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 6.88 | 980 | 6,742 | 0 | |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 2.95 | 241 | 711 | 11,680 | 11.4 K to 11.7 K (+2.11 %) |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 6.88 | 2,206 | 15,177 | 11,439 | 9.2 K to 11.4 K (+23.89 %) |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 6.88 | 2,960 | 20,365 | 9,233 | 6.3 K to 9.2 K (+47.19 %) |
May 31 2005 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 6.88 | 980 | 6,742 | 6,273 | 5.3 K to 6.3 K (+18.52 %) |
May 27 2005 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 6.21 | 25,000 | 155,250 | 25,000 | |
Apr 26 2005 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Buy | P | 7.00 | 1,000 | 7,000 | 1,000 | 0 to 1,000 |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | KAMDAR MICHAEL J | SVP, Corp. Devel. a ... | Option Exercise | A | 5.30 | 50,000 | 265,000 | 50,000 | |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Option Exercise | A | 7.00 | 30,000 | 210,000 | 30,000 | |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | A | 5.30 | 50,000 | 265,000 | 50,000 | |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Research and D ... | Option Exercise | A | 5.30 | 50,000 | 265,000 | 50,000 | |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Option Exercise | A | 5.30 | 125,000 | 662,500 | 125,000 | |
Dec 17 2004 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Senior Director, Hu ... | Option Exercise | A | 7.00 | 30,000 | 210,000 | 30,000 | |
Oct 05 2004 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | A | 5.30 | 100,000 | 530,000 | 100,000 | |
Oct 05 2004 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | A | 5.30 | 100,000 | 530,000 | 100,000 | |
Sep 24 2004 | ANDS | ANADYS PHARMACEUTI ... | HENSON HEIDI | Director of Finance | Option Exercise | A | 7.95 | 5,000 | 39,750 | 22,034 | |
Apr 02 2004 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Buy | P | 7.00 | 140,000 | 980,000 | 649,902 | 509.9 K to 649.9 K (+27.46 %) |